Jun 12, 2019 - Names on the move ahead of the open.
Jun 12, 2019 - Teva Pharmaceutical Industries (TEVA -4.2%) slumps on modestly higher volume. Shares are now exchanging hands at the lowest prices in 19 years. The stock continues to fight pricing headwinds, the cont
Jun 07, 2019 - Teva Pharmaceutical Industries Ltd. (TEVA) closed at $9.26 in the latest trading session, marking a -1.59% move from the prior day.
Jun 07, 2019 - The FDA and the EMA accept Celgene's (CELG) multiple sclerosis candidate, ozanimod, for review.
Jun 06, 2019 - Lilly's (LLY) CGRP antibody, Emgality, becomes the first and only medicine approved to treat episodic cluster headache in adults.
Jun 03, 2019 - Here are the biggest calls on Wall Street on Monday
Jun 03, 2019 - Oppenheimer issues rating change for TEVA
May 31, 2019 - Biogen (BIIB) announces new interim results from phase III EVOLVE-MS-1 study, which showed that the diroximel fumarate was generally well tolerated in people with relapsing MS.
May 30, 2019 - Here are the biggest calls on Wall Street on Thursday
May 29, 2019 - "Now that people are really freaking out ... I think it's time to start picking up stocks into weakness," Jim Cramer says.